GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » FibroGen Inc (STU:1FG) » Definitions » Investments And Advances

FibroGen (STU:1FG) Investments And Advances : €5.3 Mil (As of Mar. 2024)


View and export this data going back to 2015. Start your Free Trial

What is FibroGen Investments And Advances?

FibroGen's Investments And Advances for the quarter that ended in Mar. 2024 was €5.3 Mil.

FibroGen's quarterly Investments And Advances increased from Sep. 2023 (€4.2 Mil) to Dec. 2023 (€4.9 Mil) and increased from Dec. 2023 (€4.9 Mil) to Mar. 2024 (€5.3 Mil).

FibroGen's annual Investments And Advances declined from Dec. 2021 (€151.9 Mil) to Dec. 2022 (€8.9 Mil) and declined from Dec. 2022 (€8.9 Mil) to Dec. 2023 (€4.9 Mil).


FibroGen Investments And Advances Historical Data

The historical data trend for FibroGen's Investments And Advances can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

FibroGen Investments And Advances Chart

FibroGen Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Investments And Advances
Get a 7-Day Free Trial Premium Member Only Premium Member Only 55.01 2.44 151.89 8.88 4.85

FibroGen Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Investments And Advances Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 5.50 5.64 4.25 4.85 5.31

FibroGen Investments And Advances Calculation

Investments And Advances includes all the non-current investments in affiliates, real estate, securities, etc.


FibroGen (STU:1FG) Business Description

Traded in Other Exchanges
Address
409 Illinois Street, San Francisco, CA, USA, 94158
FibroGen Inc is a biotechnology company focused on discovering, developing, and commercializing novel therapeutics to treat serious unmet medical needs. The company generates the vast majority of its revenue in Europe, followed by Japan. Virtually all of FibroGen's revenue to date has been generated from its collaboration agreements. FibroGen seeks partners with research, development, and marketing capabilities and other resources that strengthen the company's ability to advance product candidates.

FibroGen (STU:1FG) Headlines

No Headlines